312-422-1111 ibioadmin@ibio.org

Meet Marilyn Vetter, iBIO Board Chair

iBIO is thrilled to start the week with an exciting announcement: Marilyn Vetter, group vice president, U.S. access strategy at Horizon Therapeutics, transitioned from vice-chair to chair of the iBIO board, and Harry Rowland, Ph.D., co-founder and chief executive...
X